Industry

AmpliPhi Biosciences to be Granted European Patent Covering the Use of Phage Therapy to Resensitize Bacterial Infections To Antibiotics

AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today

Industry

Oncodesign is Granted New Patent Protecting Key Molecules Generated from Its Nanocyclix Technology Platform for Next Generation Kinase Inhibitors

Oncodesign  (Paris:ALONC) (ALONC – FR0011766229), a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight